Beauty writer Larry Stansbury tested the La Roche-Posay Mela B3 Dark Spot Serum for 12 weeks. Here, see his results and read ...

After tons of trial and error, I finally discovered a lineup that delivered smooth, silky, and healthy skin. Better yet?

Roche argued that its obesity medications would prove to have advantages over its rivals’ — and that the demand for weight ...

La Roche-Posay, and more are designed to fade wrinkles, firm skin, and reintroduce hydration. No matter your skin type, there are certain products and ingredients everyone should use if they're ...

The the Swiss drugmaker will face off in the obesity area with leaders Novo Nordisk A/S and Indianapolis-based Eli Lilly and ...

In the second part of the skincare series, The Business Standard has gathered a few products for dry skin to help you achieve hydration and a balanced, radiant look ...

Prioritizing your skincare routine is essential to maintaining a youthful glow and tackling early signs of aging As you ...

Roche (RHHBY) reportedly sees three obesity/diabetes drug candidates acquired through its takeover of Carmot having the ...

The pharma company said it believes there’s plenty of room for multiple industry players in the obesity drug market.

Strategist writer Rachael Griffiths declared that “the best blue mascara is $13” — but it’s down to just $9 during the sale.

The acquisition of the Vacaville facility significantly extends Lonza’s capacity for mammalian manufacturing in the U.S.

Roche Holding AG has more than five medicines that it could combine with weight-loss drugs, Chief Executive Officer Thomas Schinecker said, as the Swiss drugmaker tries to crack the pharmaceutical ...